Subsequent experiments demonstrated that circ_0008602, named circGUCY1A2, acts as a ceRNA to counteract miR-200c-3p-mediated PTEN inhibition, thereby inhibiting PI3K/AKT signaling pathway and NSCLC tumorigenesis. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.